Veracyte, Inc.

@Veracyte

Leading in the Age of Evidence, genomic diagnostic products

South San Francisco, CA
Vrijeme pridruživanja: svibanj 2010.

Tweetovi

Blokirali ste korisnika/cu @Veracyte

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Veracyte

  1. 24. sij

    Dr. Clifford Hudis, CEO, speaking with re: challenges for in the next decade: “The big issue will be access and affordability. And proving that some of these [new] therapies are demonstrably better and defining what ‘better’ means.”

    Poništi
  2. 24. sij

    Dr. Clifford Hudis on ’s big data initiative: “Our data looks exactly like America. It’s not pristine data because it includes everything. It gives us a broader view into the real world.”

    Poništi
  3. 24. sij

    Dr. Clifford Hudis, CEO of , in fireside chat with at : “When you look across the spectrum of healthcare, I defy you to find a consistent definition of quality. ... The easy thing to measure is process. That doesn’t equate to outcomes.”

    Poništi
  4. 24. sij

    Join our CEO, Bonnie Anderson, and Dr. Clifford Hudis, CEO of tomorrow at for a fireside chat about the future of data-driven cancer care. Fri., Jan. 24, 9 a.m., Track 3.

    Poništi
  5. proslijedio/la je Tweet
    22. sij

    What an honor it is to introduce Brook Byers tonight as the winner of the Pioneer Award. Brook was a founding funder of Veracyte and so many other companies that today are making a reality for patients.

    Poništi
  6. 15. sij

    Data science is increasingly changing how physicians diagnose, manage and treat cancer patients. Want to know what’s happening and what’s next? Tune in to Bonnie Anderson’s fireside chat with Dr. Clifford Hudis, CEO of , at on Friday, Jan. 24, 9 a.m. (Track 3).

    Poništi
  7. 15. sij

    . on Veracyte’s sponsorship of the 2019 Mt. Kilimanjaro : "We aligned on a series of initiatives to make all employees a part of the journey." Result? >$100K in Veracyte donations, with 75% of employees participating.

    Poništi
  8. 15. sij

    ., at panel, on how he got started rallying the community to climb mountains and raise $ for cancer research: “I try to make the world better in my journalism. But, I thought, there’s got to be more.”

    Poništi
  9. proslijedio/la je Tweet
    14. sij

    Great to kick off at the opening bell ringing this morning with Keith Kennedy, Veracyte’s awesome CFO/COO!

    Poništi
  10. 8. sij

    We’re excited to announce a biopharmaceutical collaboration with Acerta Pharma and AstraZeneca — which is enabled by our expanding global footprint and tests in new oncology indications.

    Poništi
  11. 20. pro 2019.

    Congratulations to Dr. Jonathan Chung, recipient of an 2019 Alfred Soffer Research Award for his role in research demonstrating that our Genomic Classifier combined w/HRCT supports a more confident diagnosis!

    Poništi
  12. 9. pro 2019.

    We took time out on Friday to celebrate our major step towards expanding our business internationally.

    Poništi
  13. proslijedio/la je Tweet
    3. pro 2019.

    Veracyte is paying $50M for global rights to develop and commercialize diagnostic tests on NanoString's flagship gene analysis tech. Deal is combination of cash & stock...

    Prikaži ovu nit
    Poništi
  14. 3. pro 2019.

    We are excited to announce a strategic transaction that will enable us to bring our advanced genomic tests to physicians and their patients around the world!

    Poništi
  15. 21. stu 2019.

    Together with , Veracyte is developing the first noninvasive nasal swab classifier for early detection and diagnosis of . Come hear our CEO Bonnie Anderson share more!

    Poništi
  16. 21. stu 2019.

    We come to work every day to detection and diagnosis for thousands of patients and their families. Thanks to for the opportunity to share what inspires us during .

    Poništi
  17. 20. stu 2019.

    . suggests several great ways to help the community during . Check out their blog below!

    Poništi
  18. 15. stu 2019.

    Good news from : The survival rate has increased dramatically over the past 10 years. We’re proud to be part of the community that is working to save more lives through earlier disease detection and diagnosis.

    Poništi
  19. proslijedio/la je Tweet
    8. stu 2019.

    Kudos for developing a genomic classifier into clinical practice - it’s really hard & you did that!

    Poništi
  20. 8. stu 2019.

    We are honored that Dr. Sangeeta Bhorade, our medical director of pulmonology, had the opportunity to share an overview of our Genomic Classifier @ today. The genomic test has now been used at >135 US hospitals to help improve diagnosis.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·